The FDA's recommendations serve to inform potential research sponsors on development protocols for psychedelics and to solicit comment from industry.
Briana Contreras
Advertisement
Articles by Briana Contreras
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Patient Care Online
1
Early Liver Disease Detection Starts in Primary Care: A Q&A With Stevan Gonzalez, MD
2
FDA Fast Tracks Remlifanserin Development for Alzheimer Disease Psychosis
3
2026 Dyslipidemia Guideline Expands Statin Eligibility to 21.5 Million More US Adults
4
ACOG Releases New Guidance on HIV Screening and Prevention
5